個案總覽

The president of Industrial Accessories Ltd. (IAL) was preparing for a meeting to consider a management buyout of IAL. IAL was a privately owned maker of attachments for construction vehicles based in British Columbia, Canada. IAL was founded in 1970 by Gerald Stone, now chairman and CEO of IAL. Stone had decided to sell IAL because of health problems. Because he had no suitable heirs to take on leadership of the company, the president and three other senior managers were considering a buyout strategy. Students must size up the acquisition, a place value on the company and propose a financing plan for the acquisition.

A Chinese investment banker is performing due diligence on the potential acquisition of a Canadian manufacturer of health care products. Among her tasks is the need to put a value on the acquisition target. Her client is an independently wealthy investor and chair of Great Wall Holdings (Great Wall). Great Wall was a privately held conglomerate with interests in a wide range of companies. The investment banker is interested in diversifying his holdings outside of China and was especially interested in gaining a modest foothold in the manufacture of health care products in North America.

The president of Industrial Accessories Ltd. (IAL) was preparing for a meeting to consider a management buyout of IAL. IAL was a privately owned maker of attachments for construction vehicles based in British Columbia, Canada. IAL was founded in 1970 by Gerald Stone, now chairman and CEO of IAL. Stone had decided to sell IAL because of health problems. Because he had no suitable heirs to take on leadership of the company, the president and three other senior managers were considering a buyout strategy. Students must size up the acquisition, a place value on the company and propose a financing plan for the acquisition.

A Chinese investment banker is performing due diligence on the potential acquisition of a Canadian manufacturer of health care products. Among her tasks is the need to put a value on the acquisition target. Her client is an independently wealthy investor and chair of Great Wall Holdings (Great Wall). Great Wall was a privately held conglomerate with interests in a wide range of companies. The investment banker is interested in diversifying his holdings outside of China and was especially interested in gaining a modest foothold in the manufacture of health care products in North America.

This technical note discusses the methods and factors that investment bankers and venture capitalists take into account when placing a value on the shares of biotech companies.

Two managers attending a week-long executive education course are working on an assignment which requires them to estimate the cost of capital for EnCana Corporation, a leading North American oil and gas producer. The two managers disagree about which costs need to be taken into account to complete the assignment. They are not sure about the costs of different sources of capital, the overall cost of capital and the appropriate use of the hurdle rate.

Two managers attending a week-long executive education course are working on an assignment which requires them to estimate the cost of capital for EnCana Corporation, a leading North American oil and gas producer. The two managers disagree about which costs need to be taken into account to complete the assignment. They are not sure about the costs of different sources of capital, the overall cost of capital and the appropriate use of the hurdle rate.

The vice-president of finance for Westwood Plastics, Inc. (Westwood), wants to assess the impact of the possibility of a weakening Canadian dollar on the company's financial health given its exposure to the Euro. Because Westwood is required by a loan covenant to generate a minimum level of pre-tax earnings, management is concerned about the possible impact of the exchange rate volatility on projected income and cash flows. The vice-president of finance is considering both an option and a forward strategy to minimize the foreign exchange risk Westwood is facing. She must decide how to use financial instruments to hedge the risk.

A partner in a venture capital firm is contemplating an investment in a software firm. He must perform a size up of the company and prepare a term sheet.

A small proprietary trader of securities considers setting up a full service investment bank in the life sciences sector in the United States. This business opportunity has arisen because the Canadian government has been gradually lifting foreign ownership limits, US small cap companies are not as well-represented in stock portfolios of Canadians, and the US market is not as over-serviced by analysts as the Canadian market in life sciences and healthcare in particular. Several decisions need to be made including what types of services to offer, how many analysts to hire, where to set up the main office, and how to obtain the capital investment that is required.

A venture capitalist must prepare a memorandum for his investment committee outlining the opportunities and challenges presented by financing a leveraged management buyout of Grace Bioremediation Technologies, a company involved in developing manufacturing and marketing soil and water bioremediation technologies. He must decide the appropriate rate of return, assess risks and opportunities and design a term sheet containing the details of a deal structure that includes major clauses required for any loan and shareholders' agreements.

The head of clinical trials at Solnyx Pharmaceuticals had just been handed the results of a phase II trial of Atoxeril, a hypertension drug. Her task was to interpret these data in preparation for a meeting with her institutional review board and representatives of the Food and Drug Administration. This case introduces a number of concepts related to the analysis of clinical trials including dealing with missing data, ANOVA, regression and sample size calculations. Students will evaluate the design of the phase II clinical trial and interpret the trial results; they will also evaluate the implications of the angioedema incidence and how it might affect the design of a phase III trial.

The head of clinical trials at Solnyx Pharmaceuticals had just been handed the results of a phase II trial of Atoxeril, a hypertension drug. Her task was to interpret these data in preparation for a meeting with her institutional review board and representatives of the Food and Drug Administration. This case introduces a number of concepts related to the analysis of clinical trials including dealing with missing data, ANOVA, regression and sample size calculations. Students will evaluate the design of the phase II clinical trial and interpret the trial results; they will also evaluate the implications of the angioedema incidence and how it might affect the design of a phase III trial.

This note describes the TSX Venture Exchange in the early 2000s, which is dedicated to the listing and trading of share in junior companies. It also includes a discussion on the advantages and disadvantages of such listing.

Excel spreadsheet for product 9A96B050.

Representatives of the technology transfer office are preparing a commercialization strategy of a new peptide. The function of the technology transfer office at the University of Western Ontario is to prospect for suitable technologies for commercialization, to manage the patent protection for such inventions, and to identify ways to develop such inventions. Two licensing opportunities are being considered, both of which entail creation of a startup company. The representatives must evaluate options to determine which offers the best potential for the commercialization of the invention for everyone involved.

Representatives of the technology transfer office are preparing a commercialization strategy of a new peptide. The function of the technology transfer office at the University of Western Ontario is to prospect for suitable technologies for commercialization, to manage the patent protection for such inventions, and to identify ways to develop such inventions. Two licensing opportunities are being considered, both of which entail creation of a startup company. The representatives must evaluate options to determine which offers the best potential for the commercialization of the invention for everyone involved.

Excel spreadsheet for product 9B04N004.

Instructor's Excel spreadsheet for product 8A94B08.

Student's Excel spreadsheet for product 9A94B008.